Sam Hancock

M.Sci. Genetics

Sam completed his MSci in Genetics at the University of Nottingham in 2019, fuelled initially by an interest in genetic ageing. As part of his degree, he also investigated the role of rnh genes in originless replication in archaea.

Articles from Sam

Evaluating the use of megadoses of corticosteroids as a treatment of COVID-19

In a new study, researchers have been investigating the effects of megadoses of corticosteroids on hospitalized COVID-19 patients.

26 Jan 2022

How long does COVID-19 remain traceable on food?

In a new study, researchers identified the effective lengths at which SARS-CoV-2 can survive on certain foods, which can likely act as a model to predict how well it could survive on many others.

26 Jan 2022

Study suggests COVID-19 patient fatalities are decreasing unequally in vaccinated and unvaccinated countries

Researchers from the University of London have been exploring the case-fatality rate of COVID-19 in the top-vaccinated countries compared to the rest of the world.

25 Jan 2022

Researchers examine benefits of lateral flow testing with regards to the new Paxlovid drug for treatment of COVID-19

In a new study, researchers from Harvard University explored the benefits of different COVID-19 testing schemes with regards to the new Paxlovid drug.

24 Jan 2022

Characterization of unique pathogenesis of SARS-CoV-2 Delta variant in mouse model

Researchers have investigated the pathology and inflammatory response to the Delta variant in mice.

24 Jan 2022

Alpaca-derived antibody fragment disrupts interaction between SARS-CoV-2 spike protein and human ACE2

Researchers have been investigating the potential for using nanobodies – special immune particles from llamas and alpacas – against the disease.

24 Jan 2022

Researchers design neural network to predict severity of COVID-19 variants

In a new study, researchers predict the risk of infection with severe coronavirus disease 2019 from the sequence of the spike protein.

21 Jan 2022

Call for pharmaceutical companies to release COVID-19 vaccine data

Scientists are beginning to grow worried about the seeming reluctance of these companies to release the raw data from the clinical trials.

21 Jan 2022

Study explores whether gut bacteria profiles differ by race and insulin sensitivity status

In the present study published in PLOS ONE, researchers designed and undertook a unique study to investigate these interactions further.

21 Jan 2022

Study reports of receptor-binding domain multimer capable of enhancing the immune response against SARS-CoV-2

Researchers have discovered a new way to induce immunity against the RBD.

19 Jan 2022

Sam Hancock

Articles from Sam

Evaluating the use of megadoses of corticosteroids as a treatment of COVID-19

How long does COVID-19 remain traceable on food?

Study suggests COVID-19 patient fatalities are decreasing unequally in vaccinated and unvaccinated countries

Researchers examine benefits of lateral flow testing with regards to the new Paxlovid drug for treatment of COVID-19

Characterization of unique pathogenesis of SARS-CoV-2 Delta variant in mouse model

Alpaca-derived antibody fragment disrupts interaction between SARS-CoV-2 spike protein and human ACE2

Researchers design neural network to predict severity of COVID-19 variants

Call for pharmaceutical companies to release COVID-19 vaccine data

Study explores whether gut bacteria profiles differ by race and insulin sensitivity status

Study reports of receptor-binding domain multimer capable of enhancing the immune response against SARS-CoV-2

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News